Cover Image
市場調查報告書

流感疫苗:流行病學、病患人數的市場預測,治療流程,已上市/開發平台藥物分析

Influenza vaccines: Epidemiology and patient-based market forecasts, treatment algorithm, and marketed and pipeline drug analysis

出版商 Datamonitor Healthcare 商品編碼 365205
出版日期 內容資訊 英文 99 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
流感疫苗:流行病學、病患人數的市場預測,治療流程,已上市/開發平台藥物分析 Influenza vaccines: Epidemiology and patient-based market forecasts, treatment algorithm, and marketed and pipeline drug analysis
出版日期: 2016年02月01日 內容資訊: 英文 99 Pages
簡介

本報告提供已上市/臨床實驗中 (開發平台上)的流感疫苗相關分析,各產品的市場規模的估計值,疾病的流行週期帶給市場趨勢的影響,及今後的疫苗接種率預測,新型的4價值流感病毒 (QIV)普及促進、阻礙因素,提高嬰兒、老年人的疫苗接種率的有效手段,佐劑疫苗和類病毒顆粒 (VLP) 疫苗的上市對市場產生的影響等相關調查。

市場預測:季節性流感疫苗

  • 摘要整理
  • 市場概要與趨勢
  • 市場定義
  • 對4價值流感病毒 (QIV) 的轉換:主要的促進、阻礙因素
  • 美國市場的預測
  • 法國市場預測
  • 德國市場預測
  • 義大利市場預測
  • 西班牙市場預測
  • 英國市場預測
  • 主要的意見領袖分析

開發中產品:季節性流感疫苗

  • 摘要整理
  • 臨床實驗開發平台概要
  • 產品簡介 (最後階段):MF-59佐劑QIV
  • 產品簡介 (最後階段):類病毒顆粒 (VLP)的QIV

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: DMKC10628

The seasonal influenza vaccines market will be boosted by the broadening of vaccination recommendations within the EU markets to include school-aged children, and the gradual adoption of premium-priced quadrivalent influenza vaccines (QIVs).

This report addresses the following questions:

  • How will new and changing recommendations impact vaccines sales?
  • How will vaccination coverage rates for influenza change over the forecast period?
  • Which factors will be drivers and resistors of uptake for novel QIVs?
  • Which vaccine approaches have the greatest potential to improve protection for infants and the elderly?
  • How will the launches of adjuvanted and virus-like particle QIVs affect the landscape of the seasonal influenza vaccines market?

TABLE OF CONTENTS

FORECAST: SEASONAL INFLUENZA VACCINES

  • 1. Executive Summary
  • 2. Market Overview and Trends
  • 3. Market Definition
  • 4. Key Drivers and Resistors of Conversion To QIVs
  • 5. US Market Forecast
  • 6. France Market Forecast
  • 7. Germany Market Forecast
  • 8. Italy Market Forecast
  • 9. Spain Market Forecast
  • 10. UK Market Forecast
  • 11. Key Opinion Leader Research

PIPELINE: SEASONAL INFLUENZA VACCINES

  • 12. Executive Summary
  • 13. Clinical Pipeline Overview
  • 14. Product profile (late stage): MF-59 adjuvanted QIV
  • 15. Product profile (late stage): VLP QIV
Back to Top